ISOVUE-M 408 mg/mL

ISOVUE-M 408 mg/mL is an iodinated contrast media injection used for diagnostic imaging procedures. This single-dose solution is designed for intrathecal administration, providing clear visualization of spinal structures.

ISOVUE-M 408 mg/mL is primarily used in medical imaging to enhance the visibility of spinal structures during diagnostic procedures. It is administered intrathecally, making it suitable for procedures that require detailed imaging of the spinal cord and surrounding areas. This contrast media helps healthcare professionals obtain clear images, aiding in the diagnosis and evaluation of various spinal conditions.

When administered intrathecally, ISOVUE-M 408 mg/mL may cause temporary discomfort or warmth at the injection site. Some individuals might experience mild headaches or nausea following the procedure. These effects are generally short-lived and subside quickly.

ISOVUE-M 408 mg/mL should be used with caution in individuals with a history of allergic reactions to iodinated contrast media. It is important to inform healthcare providers about any known allergies or sensitivities before administration. Proper handling and storage are essential to maintain the integrity and effectiveness of the solution.

ISOVUE-M 408 mg/mL may interact with certain medications or substances, particularly those that affect kidney function. It is advisable to consult with a healthcare provider regarding potential interactions, especially if taking other medications or supplements. Alcohol and certain over-the-counter drugs may also influence the body's response to this contrast media.